

| カタログ番号 | AV974028 |
|---|---|
| 説明 |
Anti-Durvalumab ELISA Kit (AV974028) — Quantitative sandwich ELISA for Anti-Durvalumab. Sample: Plasma, Serum. Range: 156.25 - 10, 000 ng/mL.
Highlights
|
| アプリケーション | ELISA |
| アクセッション番号 | Q9NZQ7 |
| 検出方法 | Colorimetric |
| サンプルタイプ | Plasma, Serum |
| アッセイタイプ | Quantitative |
| レンジ | 156.25 - 10, 000 ng/mL |
| 回収率 | 80-120% |
| 発送 | 2-8 ℃ |
| 安定性と保存 | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| 仕様 | Durvalumab |
| 別名 | MEDI4736, 1428935-60-7 |
| 背景 | Programmed cell death 1 ligand 1 (Durvalumab) is a ~33 kDa protein. Plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response. Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10). Can also act as a transcription coactivator: in response to hypoxia, translocates into the nucleus via its interaction with phosphorylated STAT3 and promotes transcription of GSDMC, leading to pyroptosis. 1. Freeman, GJ. et al. (2000) The Journal of experimental medicine 192, 1027-34. PMID: 11015443 2. Mezzadra, R. et al. (2017) Nature 549, 106-110. PMID: 28813410 3. Burr, ML. et al. (2017) Nature 549, 101-105. PMID: 28813417 4. Huang, X. et al. (2019) Cancer immunology research 7, 1580-1590. PMID: 31399419 5. Kennedy, A. et al. (2023) The EMBO journal 42, e111556. PMID: 36727298 6. Dong, H. et al. (1999) Nature medicine 5, 1365-9. PMID: 10581077 7. Hou, J. et al. (2020) Nature cell biology 22, 1264-1275. PMID: 32929201 |
| 注意事項 | For Research Use Only. |
+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206

中文
English
한국어
日本語
Español
Français
Русский